Unknown

Dataset Information

0

Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.


ABSTRACT: OBJECTIVE:We propose that metastatic epithelial ovarian cancer (EOC) is a potential therapeutic target for the oncolytic agent, Myxoma virus (MYXV). METHODS:Primary EOC cells were isolated from patient ascites and cultured as adherent cells or in suspension using Ultra Low-Attachment dishes. MYXV expressing green fluorescent protein was used to infect cells and spheroids. Infection was monitored by fluorescence microscopy, viral titering and immunoblotting for M-T7 and M130 virus protein expression, and cell viability by alamarBlue assay. Akti-1/2 (5 ?M) and rapamycin (20 nM) were used to assay the role of PI3K-AKT signaling in mediating MYXV infection. RESULTS:Ascites-derived EOC cells grown in adherent culture are effectively killed by MYXV infection. EOC cells grown in suspension to form three-dimensional EOC spheroids readily permit MYXV entry into cells, yet are protected from the cytopathic effects of late MYXV infection. Upon reattachment (to model secondary metastasis), EOC spheroids are re-sensitized to MYXV-mediated oncolysis. The critical determinant that facilitates efficient MYXV infection is the presence of an activated PI3K-AKT signaling pathway. Treatment with the specific AKT inhibitor Akti-1/2 reduces infection of monolayer EOC cells and spheroids. Direct infection of freshly-collected ascites demonstrated that 54.5% of patient samples were sensitive to MYXV-mediated oncolytic cell killing. We also demonstrate that factor(s) present in ascites may negatively impact MYXV infection and oncolysis of EOC cells, which may be due to a down-regulation in endogenous AKT activity. CONCLUSIONS:Differential activity of AKT serves as the mechanistic basis for regulating MYXV-mediated oncolysis of EOC spheroids during key steps of the metastatic program. In addition, we provide the first evidence that MYXV oncolytic therapy may be efficacious for a significant proportion of ovarian cancer patients with metastatic disease.

SUBMITTER: Correa RJ 

PROVIDER: S-EPMC4373451 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.

Correa Rohann J M RJ   Komar Monica M   Tong Jessica G K JG   Sivapragasam Milani M   Rahman Masmudur M MM   McFadden Grant G   Dimattia Gabriel E GE   Shepherd Trevor G TG  

Gynecologic oncology 20120201 2


<h4>Objective</h4>We propose that metastatic epithelial ovarian cancer (EOC) is a potential therapeutic target for the oncolytic agent, Myxoma virus (MYXV).<h4>Methods</h4>Primary EOC cells were isolated from patient ascites and cultured as adherent cells or in suspension using Ultra Low-Attachment dishes. MYXV expressing green fluorescent protein was used to infect cells and spheroids. Infection was monitored by fluorescence microscopy, viral titering and immunoblotting for M-T7 and M130 virus  ...[more]

Similar Datasets

| S-EPMC4146408 | biostudies-literature
| S-EPMC8486214 | biostudies-literature
| S-EPMC7374705 | biostudies-literature
| S-EPMC4376281 | biostudies-literature
| S-EPMC6421628 | biostudies-literature
| S-EPMC4965858 | biostudies-literature
| S-EPMC8593816 | biostudies-literature
| S-EPMC8901794 | biostudies-literature
| S-EPMC7843216 | biostudies-literature
| S-EPMC3583847 | biostudies-literature